• ქართული
  • English
  • S&P 500 slips after report on coronavirus drug trial

    The S&P 500 ended marginally lower on Thursday after a report that an experimental antiviral drug for the coronavirus flopped in its first randomized clinical trial, denting optimism that the pandemic’s impact on the labor market was nearing an end.

    Market Quotes by TradingView